|
|
||||||||
The Journal of Neurophysiology Vol. 87 No. 3 March 2002, pp. 1369-1375
Copyright ©2002 by the American Physiological Society
The Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201
Brundege, James M. and
John T. Williams.
Increase in Adenosine Sensitivity in the Nucleus Accumbens
Following Chronic Morphine Treatment. J. Neurophysiol. 87: 1369-1375, 2002. There is a growing
body of evidence suggesting that the neuromodulator adenosine is
involved in drug addiction and withdrawal and that adenosine signaling
pathways may offer new targets for therapeutic treatments of addiction.
Recent studies have suggested that chronic exposure to drugs of abuse
may alter adenosine metabolism in the nucleus accumbens, a brain region
critically involved in drug addiction and withdrawal. The present study
examined the effects of chronic morphine treatment on the ability of
adenosine to inhibit excitatory postsynaptic currents in nucleus
accumbens medium spiny neurons. It was found that chronic morphine
treatment via subcutaneous implantation of morphine pellets in rats for 1 wk did not alter the level of adenosine-mediated tonic inhibition of
nucleus accumbens excitatory synapses. However, chronic morphine treatment did induce a leftward shift in the adenosine dose-response curve, indicating an increase in the sensitivity of synaptic currents to exogenously applied adenosine. This shift was not due to a change in
adenosine receptors or their effectors, because chronic morphine
treatment had no effect on the dose-response relationship of a
nonmetabolized adenosine receptor agonist. When adenosine transport was
blocked, the ability of chronic morphine to shift the adenosine
dose-response curve was eliminated. These experiments suggest that the
increase in the sensitivity of nucleus accumbens synapses to the
inhibitory effects of adenosine may be due to a decrease in adenosine
transport. The identification of these changes in the adenosine system
after chronic drug exposure may help identify new therapeutic
strategies aimed at easing withdrawal from opioids.
This article has been cited by other articles:
![]() |
J. N. Peart and G. J. Gross Morphine-Tolerant Mice Exhibit a Profound and Persistent Cardioprotective Phenotype Circulation, March 16, 2004; 109(10): 1219 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yao, P. Fan, Z. Jiang, W. S. Mailliard, A. S. Gordon, and I. Diamond Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-{beta}{gamma} dimers PNAS, November 25, 2003; 100(24): 14379 - 14384. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Alonzo and B. M. Bayer Antagonism of N-Methyl-D-aspartate Receptors Reduces the Vulnerability of the Immune System to Stress after Chronic Morphine J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 793 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Hoffman, M. Oz, T. Caulder, and C. R. Lupica Functional Tolerance and Blockade of Long-Term Depression at Synapses in the Nucleus Accumbens after Chronic Cannabinoid Exposure J. Neurosci., June 15, 2003; 23(12): 4815 - 4820. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |